Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases is a research paper published in Current Opinion in Pharmacology (2022). On theSindex it has a DataRank of 0.464. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: UL1 9AI110483
National Center for Advancing Translational Sciences
Grant: UL1 TR002345
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: K23 AR073927
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: P30 AR070253
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: P30 AR072577
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: P30 AR073752
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01 AR077607
Leona M. and Harry B. Helmsley Charitable Trust
Bristol-Myers Squibb
Gilead Sciences
Foghorn Therapeutics
National Institutes of Health
Pfizer
GlaxoSmithKline
Rheumatology Research Foundation
MeSH Terms